Abcellera BiologicsInc Ownership
| ABCL Stock | USD 3.90 0.07 1.76% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Abcellera |
Abcellera Stock Ownership Analysis
About 28.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.1. Some equities with similar Price to Book (P/B) outperform the market in the long run. Abcellera BiologicsInc has Price/Earnings To Growth (PEG) ratio of 2.22. The entity recorded a loss per share of 0.51. The firm had not issued any dividends in recent years. AbCellera Biologics Inc. develops antibody discovery platform. The company was incorporated in 2012 and is headquartered in Vancouver, Canada. Abcellera Biologics is traded on NASDAQ Exchange in the United States. For more info on Abcellera BiologicsInc please contact Carl Hansen at 604-559-9005 or go to https://www.abcellera.com.Besides selling stocks to institutional investors, Abcellera BiologicsInc also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Abcellera BiologicsInc's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Abcellera BiologicsInc's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Abcellera BiologicsInc Quarterly Liabilities And Stockholders Equity |
|
Abcellera BiologicsInc Insider Trades History
About 28.0% of Abcellera BiologicsInc are currently held by insiders. Unlike Abcellera BiologicsInc's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Abcellera BiologicsInc's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Abcellera BiologicsInc's insider trades
Abcellera Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Abcellera BiologicsInc is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abcellera BiologicsInc backward and forwards among themselves. Abcellera BiologicsInc's institutional investor refers to the entity that pools money to purchase Abcellera BiologicsInc's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Casdin Capital, Llc | 2023-12-31 | 2.4 M | Fidelity International Ltd | 2023-12-31 | 1.9 M | Guardian Capital Advisors Lp | 2023-12-31 | 1.8 M | Prosight Management, Lp | 2023-12-31 | 1.7 M | Renaissance Technologies Corp | 2023-12-31 | 1.5 M | Millennium Management Llc | 2023-12-31 | 1.3 M | Goldman Sachs Group Inc | 2023-12-31 | 1.2 M | Novo A/s | 2023-12-31 | 1.1 M | Two Sigma Investments Llc | 2023-12-31 | 1.1 M | Baillie Gifford & Co Limited. | 2023-12-31 | 24 M | Baker Bros Advisors Lp | 2023-12-31 | 22.9 M |
Abcellera BiologicsInc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abcellera BiologicsInc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abcellera BiologicsInc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Abcellera BiologicsInc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Abcellera BiologicsInc Corporate Filings
F4 | 27th of February 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 23rd of February 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of February 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 13th of February 2024 An amended filing to the original Schedule 13G | ViewVerify |
Abcellera BiologicsInc Investors Sentiment
The influence of Abcellera BiologicsInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abcellera. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Abcellera BiologicsInc's public news can be used to forecast risks associated with an investment in Abcellera. The trend in average sentiment can be used to explain how an investor holding Abcellera can time the market purely based on public headlines and social activities around Abcellera BiologicsInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Abcellera BiologicsInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abcellera BiologicsInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abcellera BiologicsInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abcellera BiologicsInc.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abcellera BiologicsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abcellera BiologicsInc's short interest history, or implied volatility extrapolated from Abcellera BiologicsInc options trading.
Pair Trading with Abcellera BiologicsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abcellera BiologicsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera BiologicsInc will appreciate offsetting losses from the drop in the long position's value.Moving against Abcellera Stock
| 0.77 | XFOR | X4 Pharmaceuticals Buyout Trend | PairCorr |
| 0.69 | ACB | Aurora Cannabis Trending | PairCorr |
| 0.68 | CGC | Canopy Growth Corp Trending | PairCorr |
| 0.68 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.64 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Abcellera BiologicsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abcellera BiologicsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abcellera BiologicsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abcellera BiologicsInc to buy it.
The correlation of Abcellera BiologicsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abcellera BiologicsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abcellera BiologicsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abcellera BiologicsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Abcellera Stock analysis
When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.51) | Revenue Per Share 0.131 | Quarterly Revenue Growth (0.57) | Return On Assets (0.1) |
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.